(Market Call Minute) He likes pharma and the more North American focus. Prefers JNJ-N but is okay with this one.
(A Top Pick Feb 1/12. Up 2.18%.) Focused on special opportunities in the pharmaceutical world. Got under pressure because there were generics coming in on their key drugs but it turned out the risk wasn’t as threatening as the market had expected. Stock has been rallying lately.
Shire PLC is a American stock, trading under the symbol SHPG-Q on the NASDAQ (SHPG). It is usually referred to as NASDAQ:SHPG or SHPG-Q
In the last year, there was no coverage of Shire PLC published on Stockchase.
Shire PLC was recommended as a Top Pick by on . Read the latest stock experts ratings for Shire PLC.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 0 stock analysts on Stockchase covered Shire PLC. The stock is worth watching.
On , Shire PLC (SHPG-Q) stock closed at a price of $.
A pharmaceutical/biotech company. It has an extremely attractive valuation, dirt cheap, trading at under 11X forward earnings. This has a really good stable of rare disease drugs that are very much untouched in the marketplace. The pharmaceutical sector has been absolutely beaten up and is becoming absolutely compelling. Dividend yield of 0.53%. (Analysts’ price target is £6100.)